Issue
This issue is open to the public.
Alert me when new journal issues are available via
Title page page i Full Text | Full-Text PDF (22 KB)
Faculty List page iv Full Text | Full-Text PDF (16 KB)
Faculty Disclosures page v Full Text | Full-Text PDF (16 KB)
Introduction Michael H. Davidson pages S1-S2 Full Text | Full-Text PDF (81 KB)
Identifying the Vulnerable Patient with Rupture-Prone Plaque Howard S. Weintraub pages S3-S10 Abstract | Full Text | Full-Text PDF (529 KB)
Lipoprotein-Associated Phospholipase A2: A Risk Marker or a Risk Factor? Amir Lerman, Joseph P. McConnell pages S11-S22 Abstract | Full Text | Full-Text PDF (1263 KB)
Lipoprotein-Associated Phospholipase A2: An Independent Predictor of Coronary Artery Disease Events in Primary and Secondary Prevention Jeffrey L. Anderson pages S23-S33 Abstract | Full Text | Full-Text PDF (337 KB)
Lipoprotein-Associated Phospholipase A2 and Risk of Stroke Philip B. Gorelick pages S34-S40 Abstract | Full Text | Full-Text PDF (752 KB)
Review of the Evidence for the Clinical Utility of Lipoprotein-Associated Phospholipase A2 as a Cardiovascular Risk Marker Marshall A. Corson, Peter H. Jones, Michael H. Davidson pages S41-S50 Abstract | Full Text | Full-Text PDF (823 KB)
Consensus Panel Recommendation for Incorporating Lipoprotein-Associated Phospholipase A2 Testing into Cardiovascular Disease Risk Assessment Guidelines Michael H. Davidson, Marshall A. Corson, Mark J. Alberts, Jeffrey L. Anderson, Philip B. Gorelick, Peter H. Jones, Amir Lerman, Joseph P. McConnell, Howard S. Weintraub pages S51-S57 Abstract | Full Text | Full-Text PDF (1254 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us
